How Obesity Impacts Lifespan | Longevity, Episode 1

In the premiere episode of “Longevity," David Rubenstein explores the ongoing obesity crisis in America, examining its longstanding impact and the latest medical advancements aimed at addressing it, most notably the development of GLP-1s. He also delves into the question of whether weight-loss drugs offer a lasting solution.

Guests include:
Dave Ricks | Eli Lilly Chair & CEO
David Cordani | Cigna Chairman & CEO
Dr. Louis Aronne | Director, Comprehensive Weight Control Center at Weill Cornell Medicine
Dr. Fatima Cody Stanford | Obesity Specialist, Massachusetts General Hospital and Harvard Medical School

Longevity with David Rubenstein dives into the rapidly evolving world of medical research, pharmaceuticals, and science-backed wellness to uncover the facts behind the growing human pursuit of longer, healthier lives. In his new show, Rubenstein speaks with leading scientists, physicians and policy experts to examine one of the most urgent and captivating questions of our time: how can we live longer -- and better?

Chapters:
00:00 Longevity
02:26 - Rising Obesity Rate
04:00 Dr. Stanford on BMI
06:30 Do diets really work?
08:30 Dr. Aronne - do GLP-1s work?
11:30 Lilly's weight loss drugs
12:49 - Obesity's Effect on Health / GLP-1s
16:30 How bad is fast food for you?
19:46 - Diet and Exercise
--------
Like this video? Subscribe to The David Rubenstein Show on YouTube:
   / @davidrubenstein  

Watch the latest episodes of "The David Rubenstein Show: Peer-to-Peer Conversations" here:
https://www.bloomberg.com/peer-to-peer

Learn more about David:
http://www.davidrubenstein.com/
Connect with us on...
Twitter:   / business  
Facebook:   / bloombergbusiness  
Instagram:   / bloombergbusiness